Zimmer Biomet Holdings, Inc.
corporate_fare Company Profile
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 17 items for ZBH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-04, rated 7/10. Across its 17 most recent items scored 7 or higher, the top rating is 8/10, with 5 rated 8 or above. Recent SEC coverage for ZBH spans 10-Q, 8-K, DEF 14A, 10-K.
Recent high-impact activity:
- Zimmer Biomet 10-Q Details Q3 Earnings Dip, New $60M Plant Restructuring and $755M of Acquisitions
- Zimmer Biomet Jumps 15% to 52-Week High on Q3 Beat and Raised Guidance
- Zimmer Biomet Q3 Sales $2.06B, Raises 2026 EPS and Organic Growth Guidance
- Zimmer Biomet Posts $2.06B in Third-Quarter Sales
- Zimmer Biomet Guides FY26 Adj EPS to $8.47-$8.49, Above Consensus
Financial Snapshot
Short Interest & Short Volume
3.89 days to coverFINRA reported short interest of 7,848,223 shares in ZBH as of the October 30, 2026 settlement, a 1.4% decrease from the prior period — about 3.9 days to cover at its recent average daily volume. On November 20, 2026, 43.9% of ZBH volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.